ERCC1 and BRCA1 mRNA expressions are associated with clinical outcome of non-small cell lung cancer treated with platinum-based chemotherapy.
about
ERCC1, RRM1 and TUBB3 mRNA expression on the tumor response and overall survival of non-small cell lung cancer treated with platinum-based chemotherapyERCC1_202 Is A Prognostic Biomarker in Advanced Stage Non-Small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy.Poor response to platinum-based chemotherapy is associated with KRAS mutation and concomitant low expression of BRAC1 and TYMS in NSCLC.Diagnostic and prognostic values of the mRNA expression of excision repair cross-complementation enzymes in hepatitis B virus-related hepatocellular carcinoma
P2860
ERCC1 and BRCA1 mRNA expressions are associated with clinical outcome of non-small cell lung cancer treated with platinum-based chemotherapy.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
ERCC1 and BRCA1 mRNA expressio ...... h platinum-based chemotherapy.
@en
ERCC1 and BRCA1 mRNA expressio ...... h platinum-based chemotherapy.
@nl
type
label
ERCC1 and BRCA1 mRNA expressio ...... h platinum-based chemotherapy.
@en
ERCC1 and BRCA1 mRNA expressio ...... h platinum-based chemotherapy.
@nl
prefLabel
ERCC1 and BRCA1 mRNA expressio ...... h platinum-based chemotherapy.
@en
ERCC1 and BRCA1 mRNA expressio ...... h platinum-based chemotherapy.
@nl
P2093
P2860
P1433
P1476
ERCC1 and BRCA1 mRNA expressio ...... h platinum-based chemotherapy.
@en
P2093
Shujuan Yang
Wenjian Yao
Xianjun Feng
Xiaomeng Gu
Xiaoqing Huo
Xiuguang Qin
P2860
P2888
P304
P356
10.1007/S13277-014-1615-8
P577
2014-01-18T00:00:00Z